Preclinical Evaluation of Stable Integrin α v β 3 -Specific [ 198 Au]Gold Nanoparticles for Tumor Therapy.
Saved in:
| Title: | Preclinical Evaluation of Stable Integrin α v β 3 -Specific [ 198 Au]Gold Nanoparticles for Tumor Therapy. |
|---|---|
| Authors: | Davarci, Güllü1,2 (AUTHOR), Wängler, Carmen2,3 (AUTHOR), Eberhardt, Klaus3,4 (AUTHOR), Tulessin, Margaret4,5 (AUTHOR), Geppert, Christopher4,5 (AUTHOR), Schirrmacher, Ralf6 (AUTHOR), Fricker, Gert7 (AUTHOR), Mogler, Carolin5,8 (AUTHOR), Pretze, Marc8,9 (AUTHOR) marc.pretze@ukdd.de, Wängler, Björn1,2,9 (AUTHOR) |
| Source: | Pharmaceuticals (14248247). Nov2025, Vol. 18 Issue 11, p1670. 28p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189674641 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Preclinical Evaluation of Stable Integrin α v β 3 -Specific [ 198 Au]Gold Nanoparticles for Tumor Therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Davarci%2C+Güllü%22">Davarci, Güllü</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wängler%2C+Carmen%22">Wängler, Carmen</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eberhardt%2C+Klaus%22">Eberhardt, Klaus</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tulessin%2C+Margaret%22">Tulessin, Margaret</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Geppert%2C+Christopher%22">Geppert, Christopher</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schirrmacher%2C+Ralf%22">Schirrmacher, Ralf</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fricker%2C+Gert%22">Fricker, Gert</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mogler%2C+Carolin%22">Mogler, Carolin</searchLink><relatesTo>5,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pretze%2C+Marc%22">Pretze, Marc</searchLink><relatesTo>8,9</relatesTo> (AUTHOR)<i> marc.pretze@ukdd.de</i><br /><searchLink fieldCode="AR" term="%22Wängler%2C+Björn%22">Wängler, Björn</searchLink><relatesTo>1,2,9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Pharmaceuticals+%2814248247%29%22">Pharmaceuticals (14248247)</searchLink>. Nov2025, Vol. 18 Issue 11, p1670. 28p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189674641 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ph18111670 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 28 StartPage: 1670 Titles: – TitleFull: Preclinical Evaluation of Stable Integrin α v β 3 -Specific [ 198 Au]Gold Nanoparticles for Tumor Therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Davarci, Güllü – PersonEntity: Name: NameFull: Wängler, Carmen – PersonEntity: Name: NameFull: Eberhardt, Klaus – PersonEntity: Name: NameFull: Tulessin, Margaret – PersonEntity: Name: NameFull: Geppert, Christopher – PersonEntity: Name: NameFull: Schirrmacher, Ralf – PersonEntity: Name: NameFull: Fricker, Gert – PersonEntity: Name: NameFull: Mogler, Carolin – PersonEntity: Name: NameFull: Pretze, Marc – PersonEntity: Name: NameFull: Wängler, Björn IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 14248247 Numbering: – Type: volume Value: 18 – Type: issue Value: 11 Titles: – TitleFull: Pharmaceuticals (14248247) Type: main |
| ResultId | 1 |